| 1. |
北京高血压防治协会, 中国老年学和老年医学学会, 北京市社区卫生协会, 等. 成人高血压合并 2 型糖尿病和血脂异常基层防治中国专家共识 (2024 年版). 中国全科医学, 2024, 27(28): 3453-3475, 3482.
|
| 2. |
徐莉, 葛晶, 于鹏, 等. 中国老年人慢性病及共病模式变化研究: 基于中国健康与养老追踪调查数据. 中国全科医学, 2024, 27(11): 1296-1302.
|
| 3. |
崔春子. 中国中老年人群疾病共病模式变化趋势及其影响因素研究. 长沙: 中南大学, 2023.
|
| 4. |
徐小兵, 李迪, 孙扬, 等. 中国城乡老年人慢性病共病及其影响因素的差异性研究. 中国慢性病预防与控制, 2023, 31(6): 427-432.
|
| 5. |
Tagi VM, Mainieri F, Chiarelli F. Hypertension in patients with insulin resistance: etiopathogenesis and management in children. Int J Mol Sci, 2022, 23(10): 5814.
|
| 6. |
Santoro A, Kahn BB. Adipocyte regulation of insulin sensitivity and the risk of type 2 diabetes. N Engl J Med, 2023, 388(22): 2071-2085.
|
| 7. |
Tanase DM, Gosav EM, Costea CF, et al. The intricate relationship between type 2 diabetes mellitus (T2DM), insulin resistance (IR), and nonalcoholic fatty liver disease (NAFLD). J Diabetes Res, 2020, 2020: 3920196.
|
| 8. |
Haffner SM. Pre-diabetes, insulin resistance, inflammation and CVD risk. Diabetes Res Clin Pract, 2003, 61(Suppl 1): S9-S18.
|
| 9. |
Hill MA, Yang Y, Zhang L, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism, 2021, 119: 154766.
|
| 10. |
Muzurović E, Mikhailidis DP, Mantzoros C. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk. Metabolism, 2021, 119: 154770.
|
| 11. |
Sadeghi HM, Adeli I, Calina D, et al. Polycystic ovary syndrome: a comprehensive review of pathogenesis, management, and drug repurposing. Int J Mol Sci, 2022, 23(2): 583.
|
| 12. |
Wang J, Wu D, Guo H, et al. Hyperandrogenemia and insulin resistance: the chief culprit of polycystic ovary syndrome. Life Sci, 2019, 236: 116940.
|
| 13. |
Zhao H, Zhang J, Cheng X, et al. Insulin resistance in polycystic ovary syndrome across various tissues: an updated review of pathogenesis, evaluation, and treatment. J Ovarian Res, 2023, 16(1): 9.
|
| 14. |
Dang K, Wang X, Hu J, et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003-2018. Cardiovasc Diabetol, 2024, 23(1): 8.
|
| 15. |
Li F, Wang Y, Shi B, et al. Association between the cumulative average triglyceride glucose-body mass index and cardiovascular disease incidence among the middle-aged and older population: a prospective nationwide cohort study in China. Cardiovasc Diabetol, 2024, 23(1): 16.
|
| 16. |
Gou R, Dou D, Tian M, et al. Association between triglyceride glucose index and hyperuricemia: a new evidence from China and the United States. Front Endocrinol (Lausanne), 2024, 15: 1403858.
|
| 17. |
Han Y, Zhou Z, Zhang Y, et al. The association of surrogates of insulin resistance with hyperuricemia among middle-aged and older individuals: a population-based nationwide cohort study. Nutrients, 2023, 15(14): 3139.
|
| 18. |
Seifi N, Nosrati M, Koochackpoor G, et al. The association between hyperuricemia and insulin resistance surrogates, dietary- and lifestyle insulin resistance indices in an Iranian population: MASHAD cohort study. Nutr J, 2024, 23(1): 5.
|
| 19. |
Chen Q, Hu P, Hou X, et al. Association between triglyceride-glucose related indices and mortality among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease. Cardiovasc Diabetol, 2024, 23(1): 232.
|
| 20. |
Peng H, Pan L, Ran S, et al. Prediction of MAFLD and NAFLD using different screening indexes: a cross-sectional study in U. S. adults. Front Endocrinol (Lausanne), 2023, 14: 1083032.
|
| 21. |
朱秀媛, 顾囡囡, 陈庆, 等. 长期护理保险对老年人主观幸福感的影响——基于 CHARLS 面板数据的实证分析. 中国卫生事业管理, 2024, 41(3): 264-268.
|
| 22. |
Zhou Z, Liu Q, Zheng M, et al. Comparative study on the predictive value of TG/HDL-C, TyG and TyG-BMI indices for 5-year mortality in critically ill patients with chronic heart failure: a retrospective study. Cardiovasc Diabetol, 2024, 23(1): 213.
|
| 23. |
贾真. 老年 2 型糖尿病并阿尔茨海默病患者胰岛素抵抗与 GSK-3β的关系. 广东医科大学学报, 2022, 40(4): 395-397.
|
| 24. |
中国高血压防治指南修订委员会, 高血压联盟(中国), 中国医疗保健国际交流促进会高血压病学分会, 等. 中国高血压防治指南(2024 年修订版). 中华高血压杂志 (中英文), 2024, 32(7): 603-700.
|
| 25. |
Gregg EW, Buckley J, Ali MK, et al. Improving health outcomes of people with diabetes: target setting for the WHO global diabetes compact. Lancet, 2023, 401(10384): 1302-1312.
|
| 26. |
Yao Y, Wang B, Geng T, et al. The association between TyG and all-cause/non-cardiovascular mortality in general patients with type 2 diabetes mellitus is modified by age: results from the cohort study of NHANES 1999-2018. Cardiovasc Diabetol, 2024, 23(1): 43.
|
| 27. |
罗凌风, 张增利. 中老年人群 TyG 指数及其结合肥胖指标与高血压前期的关联性研究. 公共卫生与预防医学, 2022, 33(1): 58-62.
|
| 28. |
张梅, 李梦启, 普惠婕, 等. 对比分析彝族和汉族人群 TyG-BMI 在高血压与代谢综合征的中介作用. 现代预防医学, 2024, 51(13): 2325-2330.
|
| 29. |
闵行. 中老年人 TyG 指数与糖尿病的相关性队列研究. 兰州: 兰州大学, 2022.
|
| 30. |
葛旭红. TyG 指数及其联合人体测量指标与 2 型糖尿病发病关系的研究. 辽宁大连: 大连医科大学, 2023.
|
| 31. |
Song B, Zhao X, Yao T, et al. Triglyceride glucose-body mass index and risk of incident type 2 diabetes mellitus in Japanese people with normal glycemic level: a population-based longitudinal cohort study. Front Endocrinol (Lausanne), 2022, 13: 907973.
|
| 32. |
Zhang S, Gao L, Li S, et al. Association of non-insulin-based insulin resistance indices with disease severity and adverse outcome in idiopathic pulmonary arterial hypertension: a multi-center cohort study. Cardiovasc Diabetol, 2024, 23(1): 154.
|
| 33. |
Sampath Kumar A, Maiya AG, Shastry BA, et al. Exercise and insulin resistance in type 2 diabetes mellitus: a systematic review and meta-analysis. Ann Phys Rehabil Med, 2019, 62(2): 98-103.
|
| 34. |
黄妙恩, 罗辉, 吕应年. 血管紧张素转化酶与相关疾病的关联机制. 广东医科大学学报, 2023, 41(3): 335-339.
|
| 35. |
苏峰祥, 杨景, 唐春梅, 等. 奥美沙坦酯片联合苯磺酸氨氯地平片或络活喜治疗原发性高血压的比较观察. 广东医科大学学报, 2023, 41(4): 440-443.
|
| 36. |
Minh HV, Tien HA, Sinh CT, et al. Assessment of preferred methods to measure insulin resistance in Asian patients with hypertension. J Clin Hypertens (Greenwich), 2021, 23(3): 529-537.
|
| 37. |
Guerrero-Romero F, Simental-Mendía LE, González-Ortiz M, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab, 2010, 95(7): 3347-3351.
|
| 38. |
Yang S, Shi X, Liu W, et al. Association between triglyceride glucose-body mass index and heart failure in subjects with diabetes mellitus or prediabetes mellitus: a cross-sectional study. Front Endocrinol (Lausanne), 2023, 14: 1294909.
|
| 39. |
Huang X, He J, Wu G, et al. TyG-BMI and hypertension in Normoglycemia subjects in Japan: a cross-sectional study. Diab Vasc Dis Res, 2023, 20(3): 14791641231173617.
|